Literature DB >> 33488954

Novel Pyrimidinones as SHP2 Antagonists for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2020        PMID： 33488954      PMCID： PMC7812603          DOI： 10.1021/acsmedchemlett.0c00621

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders.

Authors:  Kai Tang; Yao-Nan Jia; Bin Yu; Hong-Min Liu
Journal:  Eur J Med Chem       Date:  2020-07-23       Impact factor: 6.514

Review 2.  Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies.

Authors:  Lei Yang; Liangzhen Zheng; Wee Joo Chng; Jeak Ling Ding
Journal:  Trends Pharmacol Sci       Date:  2019-10-29       Impact factor: 14.819

Review 3.  Therapeutic potential of targeting SHP2 in human developmental disorders and cancers.

Authors:  Dadong Shen; Wenxia Chen; Jinlin Zhu; Guofeng Wu; Runpu Shen; Meiyang Xi; Haopeng Sun
Journal:  Eur J Med Chem       Date:  2020-02-06       Impact factor: 6.514

Review 4.  Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.

Authors:  Xinrui Yuan; Hong Bu; Jinpei Zhou; Chao-Yie Yang; Huibin Zhang
Journal:  J Med Chem       Date:  2020-06-10       Impact factor: 7.446

Review 5.  Targeting SHP2 as a promising strategy for cancer immunotherapy.

Authors:  Qianqian Liu; Jiao Qu; Mingxia Zhao; Qiang Xu; Yang Sun
Journal:  Pharmacol Res       Date:  2019-12-12       Impact factor: 7.658
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.